STAT

JUNE 25, 2024

Firearm violence is officially a public health crisis in the U.S. — Surgeon General Vivek Murthy says so. In a new advisory published on Tuesday, Murthy calls attention to the health toll of gun violence, describing the size of the crisis while laying out a roadmap of research and policy interventions to curb its effects. “My hope is that framing just the profound impact and pervasive impact of gun violence in our country … can firmly take it out of the realm of politics and

363

363

PharmaVoice

JUNE 25, 2024

The FDA isn’t slated to render a decision about BMS and Karuna’s potential breakthrough schizophrenia med until September — but a biotech is already hoping to be hot on its heels.

287

287

STAT

JUNE 25, 2024

Michigan has led the nation in making inroads with its farmers as it has worked to contain spread of H5N1 bird flu infections in dairy cows. Now the state’s health authorities are trying to do the same in looking for undetected infections among farmworkers. The Michigan Department of Health and Human Services is working with an undisclosed number of farms to try to assess the risk to workers of becoming infected with the virus, which has spread to at least 25 farms in the state in the pas

363

363

PharmaVoice

JUNE 25, 2024

A COVID and flu duo could ease manufacturing and administration, potentially driving higher vaccination rates, said Moderna’s VP of North American medical affairs.

Vaccines 276

Vaccines 276

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

STAT

JUNE 25, 2024

A bipartisan group of lawmakers is urging the Biden administration to prohibit Medicare Advantage insurers from using artificial intelligence tools to deny care until it completes a systematic review of their accuracy and effects on patients. In a letter sent Tuesday, the lawmakers cited a STAT investigation in calling on the Centers for Medicare and Medicaid Services to beef up oversight of AI and algorithmic tools that discriminate against old and sick patients.

360

360

ALiEM - Pharm Pearls

JUNE 25, 2024

Dr. Sara Krzyzaniak (podcast host and Stanford University PD) and Dr. Michelle Lin (ALiEM Founder/UCSF) are joined by Dr. Jessica Bod (Yale University Clerkship Director and 2024 CDEM Clerkship Director of the Year award winner) in this episode to discuss how one might approach their emergency medicine sub-internship. Dr. Bod shares her her wealth of experience and wisdom to provide not only general advice but also answers more detailed questions like: What are some things NOT to do on a rotatio

243

243

The Guardian - Pharmaceutical Industry

JUNE 25, 2024

Alternatives to costly Wegovy and Saxenda will make such treatments more widely available worldwide Ozempic maker invests $4bn to meet US ‘skinny jab’ demand Medicines that enable dramatic weight loss are set to experience a new boom in uptake, experts have said, as the first generic versions hit the market this week at a lower cost than the original drugs.

125

125

STAT

JUNE 25, 2024

Summer is officially here, and whether you’re relaxing in the great outdoors or riding out a heat wave inside, STAT’s annual book and podcast list has you covered with a bevy of titles to check out. Read on for recommendations from the likes of FDA Commissioner Robert Califf, former CDC Director Rochelle Walensky, and former White House Covid-19 response coordinator Ashish Jha.

363

363

Pharmafile

JUNE 25, 2024

AstraZeneca has announced that Tagrisso (osimertinib) in combination with pemetrexed and platinum-based chemotherapy has been approved in Japan for the first line treatment of adult patients with locally advanced or metastatic epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC) whose tumours have exon 19 deletions or exon 21 mutations.

Chemotherapy 119

Chemotherapy 119

STAT

JUNE 25, 2024

AliveCor has spent years battling with Apple over the market for consumer heart monitoring technology. Now it’s hoping to make its imprint on professional health care with its new device, which recently received clearance from the Food and Drug Administration. The 12-lead electrocardiogram device, called the Kardia 12L ECG System, is a hand-held version of the standard ECG device usually found in hospitals and used to diagnose heart conditions.

Documentation 349

Documentation Hospitals 349

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

pharmaphorum

JUNE 25, 2024

Discover practical use cases and common concerns surrounding the implementation of generative AI (GenAI) in clinical trials. Learn how this technology is transforming the landscape of medical research.

116

116

STAT

JUNE 25, 2024

Continuous positive airway pressure “is here to stay,” sleep medicine doctor Atul Malhotra declared in a May 2024 editorial published in the Lancet. But after Eli Lilly reported the full results of its obesity drug in sleep apnea patients last week, industry watchers are now debating the lasting power of CPAP machines. The trial, run by Malhotra himself, demonstrated that Zepbound reduced the number of sleep apnea episodes in patients both who were using the machines and those who

356

356

European Pharmaceutical Review

JUNE 25, 2024

The European Commission has approved the first twice-yearly injection for relapsing and primary progressive multiple sclerosis (RMS and PPMS). Roche highlighted that as a 10-minute injection, OCREVUS ® (ocrelizumab) subcutaneous has the same twice-yearly schedule as the intravenous (IV) infusion, which was the first therapeutic to be approved for both RMS and PPMS.

Immunization 111

Immunization Immunity 111

STAT

JUNE 25, 2024

The global health toll of alcohol remains “unacceptably high” across the globe, the World Health Organization said this week. Despite alcohol’s immense health toll, however, countries are still not deploying tactics that the WHO says would help to reduce alcohol’s devastating health impacts, like access restrictions, special taxes, and prohibitions on certain types of alcohol advertising.

342

342

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

vizient

JUNE 25, 2024

The planned acquisition brings together two of the industry’s most trusted advisors to help healthcare organizations deliver high-quality patient care to their communities.

111

111

STAT

JUNE 25, 2024

Drug discovery has quickly become the most enticing place to apply artificial intelligence. Billions of dollars are being invested in AI-driven “techbios.” In an industry where nothing changes overnight, even large biopharma companies are touting AI as key to how they’re transforming their discovery engines. But in the race to integrate AI into drug discovery, investing so heavily in scaling one part of the system overlooks the rest.

Drug Development 340

Drug Development 340

Pharmaceutical Technology

JUNE 25, 2024

Novavax has sought EMA approval for its updated JN.1 Covid-19 vaccine, NVX-CoV2705, for people aged 12 years and above.

Vaccines 128

Vaccines 128

STAT

JUNE 25, 2024

As chief medical officer of Moderna, Tal Zaks used to be skeptical of genome editing. Why repair a patient’s broken gene, he would ask, with all the havoc CRISPR can wreak on DNA, when a company like Moderna can just replace that gene with regular, transient doses of mRNA? (One reason: Moderna was having immense difficulty doing just that.) On Tuesday, though, Zaks emerged after years outside the spotlight as, of all things, acting CEO of a new genome editing company.

328

328

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

The Pharmacist

JUNE 25, 2024

Fresh calls have been made to review prescription charges in England as new NHS figures show a surge in the use of pre-payment certificates (PPCs). The number of 12-month PPCs issued in 2023/24 reached 2.1 million – around 30% higher than before the pandemic, when 1.5 million PPCs were issued in 2018. This type of […] The post Pharmacists would 'rather focus on care than check millions of certificates' appeared first on The Pharmacist.

106

106

STAT

JUNE 25, 2024

Not much sets the world of transplant medicine abuzz. But in the early 2000s, a creative idea in Missouri got everyone in the field talking. For the first time, organ donors who were declared brain-dead were moved out of the hospital and into an independent, freestanding center to have their organs removed. With these patients out of the precious and limited ICU beds, the hospital could devote its time and resources to living patients.

Hospitals 300

Hospitals 300

pharmaphorum

JUNE 25, 2024

Explore the complexities of patient support in the realm of cell and gene therapies. Learn about the challenges and strategies for providing effective patient assistance in this cutting-edge field.

109

109

STAT

JUNE 25, 2024

Awareness of the harms to patients caused by errors in diagnosis and treatment has been front and center for nearly 25 years. A different kind of harm, this one affecting patients and clinicians, is only now getting the recognition it deserves. Called administrative harm, it directly influences patient care and outcomes, professional practice, and organizational efficiencies.

311

311

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Welltopia Pharmacy

JUNE 25, 2024

Vitamin K2, a lesser-known but crucial member of the vitamin K family, plays a pivotal role in human health. Unlike its more famous sibling, vitamin K1, which is primarily associated with blood clotting, vitamin K2 is increasingly recognized for its broader health benefits, including bone and cardiovascular health.

100

100

STAT

JUNE 25, 2024

Many people have interpreted as a setback the “no” vote by an advisory committee to the Food and Drug Administration on Lykos Therapeutics’ new drug application for MDMA-assisted psychotherapy for post-traumatic stress disorder. We believe it is an opportunity to build upon Lykos’ success and rally support for better-funded, well-controlled clinical trials to determine the safety and efficacy of a promising PTSD treatment.

Documentation 267

Documentation 267

BioPharma Dive

JUNE 25, 2024

The company claims it can address some of the field’s limitations with medicines delivered via messenger RNA and lipid nanoparticles.

114

114

STAT

JUNE 25, 2024

When you get sick, your path to wellness depends on more than your health care. For someone diagnosed with diabetes, for example, access to nutritious food can be just as important as insulin. Health care providers and policymakers are increasingly recognizing the health impacts of social drivers such as access to healthy food, transportation, and safe housing.

Diabetes 302

Diabetes 302

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

Express Pharma

JUNE 25, 2024

Merck announced the discontinuation of the Phase III randomized TrilynX study evaluating xevinapant plus chemoradiotherapy (CRT) in patients with unresected locally advanced squamous cell carcinoma of the head and neck (LA SCCHN). The decision follows a pre-planned interim analysis performed by the study’s Independent Data Monitoring Committee, which found that the trial would be unlikely to meet its primary objective of prolonging event-free survival.

105

105

STAT

JUNE 25, 2024

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine.  Sign up here  to receive it in your inbox on Tuesdays and Thursdays. Exclusive: Senators ask Medicare for a pay bump for drugs used with PET scans Sen. Marsha Blackburn (R-Tenn.) is leading a bipartisan group of senators to ask Medicare officials to bump payment for drugs paired with diagnostic scans that are used for, among other things,

275

275

Pharmafile

JUNE 25, 2024

ILiAD Biotechnologies has announced that it has selected Emmes Group to conduct the upcoming phase 3 trials of its lead pertussis vaccine candidate, BPZE1. The two companies are currently working to finalise a definitive agreement for the collaboration. The post ILiAD Biotechnologies announces collaboration with Emmes Group on phase 3 pertussis vaccine trial appeared first on Pharmafile.

Vaccines 97

Vaccines 97

STAT

JUNE 25, 2024

Pharmaceutical companies in the U.K. have increasingly violated a voluntary industry marketing code but complaints are also taking longer to review, according to a new analysis. As a result, the researchers argue that the growing number of infractions and inadequate policing are harming public health due to unsafe or unethical business practices. Between 2004 to 2021, the Prescription Medicines Code of Practice Authority, a self-regulatory body overseen by the Association of the British Pharmace

Pharmaceutical Companies 267

Pharmaceutical Companies Pharmaceutical Companies 267

Express Pharma

JUNE 25, 2024

ILiAD Biotechnologies, a late-stage biotech development company dedicated to the prevention of disease caused by Bordetella pertussis , announced the selection of Emmes Group, a global contract research and technology organisation, to conduct upcoming Phase III studies of its lead pertussis vaccine candidate, BPZE1. ILiAD selected Emmes Group for its expertise in vaccine development, agility in managing complex clinical trials, strong local market presence, and integrated technology capabiliti

Vaccines 105

Vaccines 105